Previous studies have shown that RFX1 is significantly downregulated in tumors such as gliomas and autoimmune diseases such as systemic lupus erythematosus (Ohashi et al., 2004; Cheng et al., 2016; Zhao et al., 2010a. The gene discussed is RFX1; the disease is systemic lupus erythematosus.